| 000 | 01260 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517145130.0 | ||
| 264 | 0 | _c20180223 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1471-2407 | ||
| 024 | 7 |
_a10.1186/s12885-017-3230-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAriaans, Gerke | |
| 245 | 0 | 0 |
_aAnti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells. _h[electronic resource] |
| 260 |
_bBMC cancer _c03 2017 |
||
| 300 |
_a232 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aCell Hypoxia |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aEverolimus _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 | _aGlycolysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetformin _xpharmacology |
| 700 | 1 | _aJalving, Mathilde | |
| 700 | 1 | _aVries, Emma Geertruida Elisabeth de | |
| 700 | 1 | _aJong, Steven de | |
| 773 | 0 |
_tBMC cancer _gvol. 17 _gno. 1 _gp. 232 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12885-017-3230-8 _zAvailable from publisher's website |
| 999 |
_c27028848 _d27028848 |
||